VIH1.DEVIH1.DEXETRA
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank44
Year-over-Year Change
Year-over-year SG&A expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P44
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
100.84%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -64.55% |
| Q4 2024 | 115.11% |
| Q3 2024 | 69.99% |
| Q2 2024 | 0.00% |
| Q1 2024 | -21.56% |
| Q4 2023 | 0.00% |
| Q3 2023 | 73.68% |
| Q2 2023 | 0.00% |
| Q1 2023 | -16.04% |
| Q4 2022 | 0.00% |
| Q3 2022 | -50.65% |
| Q2 2022 | -38.49% |
| Q1 2022 | 2295.00% |
| Q4 2021 | -79.84% |
| Q3 2021 | 400.46% |
| Q2 2021 | -80.41% |
| Q1 2021 | 539.66% |
| Q4 2020 | -83.27% |
| Q3 2020 | 570.97% |
| Q2 2020 | -85.10% |
| Q1 2020 | 550.00% |
| Q4 2019 | -83.52% |
| Q3 2019 | -1.52% |
| Q2 2019 | 3.14% |
| Q1 2019 | 6.10% |
| Q4 2018 | -1.53% |
| Q3 2018 | -2.76% |
| Q2 2018 | 2.17% |
| Q1 2018 | 0.11% |
| Q4 2017 | 2.45% |
| Q3 2017 | -3.85% |
| Q2 2017 | 7.48% |
| Q1 2017 | -23.91% |
| Q4 2016 | 16.17% |
| Q3 2016 | 0.41% |
| Q2 2016 | 13.70% |
| Q1 2016 | -13.81% |
| Q4 2015 | 18.09% |
| Q3 2015 | -0.35% |